Is National Multiple Sclerosis Society Legit?

The National Multiple Sclerosis Society demonstrates a generally stable financial position, with assets consistently exceeding liabilities across its filing history. While revenue has fluctuated, ranging from a low of $108 million in 2016 to a high of $196 million in 2019, the organization has maintained substantial assets, reaching $201 million in 2021. The most recent filing (202309) shows expenses exceeding revenue by over $23 million ($172,885,857 vs $149,451,246), indicating a deficit for that period, which warrants closer examination. However, the organization's overall asset base of $184 million in 2023 suggests it has reserves to manage such fluctuations. Spending efficiency appears to be a mixed bag. Without detailed functional expense breakdowns from the provided data, it's challenging to precisely assess program spending versus administrative and fundraising costs. The consistent 'Officer Comp=0%' across all filings is unusual and suggests that executive compensation might be reported differently or is not directly paid to officers in a way that triggers this specific line item on the 990, which could be a point of inquiry for transparency. The organization's ability to maintain significant assets while experiencing periods of deficit spending, such as in 2023, indicates a need for careful financial management to ensure long-term sustainability. Transparency regarding executive compensation is a notable area for potential improvement, given the consistent 'Officer Comp=0%' reported on the 990s despite the organization's size and complexity. While this might be due to specific reporting methods, it can create ambiguity for stakeholders. Further detailed functional expense reporting would enhance understanding of how funds are allocated across programs, administration, and fundraising, thereby improving overall financial transparency.